ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 50 filers reported holding ARCELLX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,926,923 | +36.9% | 109,446 | +20.7% | 0.00% | – |
| Q2 2023 | $2,868,092 | -50.6% | 90,705 | -51.8% | 0.00% | -100.0% |
| Q1 2023 | $5,800,138 | +133.0% | 188,255 | +134.2% | 0.00% | – |
| Q4 2022 | $2,489,769 | +40.3% | 80,367 | -15.0% | 0.00% | – |
| Q3 2022 | $1,775,000 | +221.0% | 94,578 | +208.9% | 0.00% | – |
| Q2 2022 | $553,000 | +4153.8% | 30,618 | +3257.2% | 0.00% | – |
| Q1 2022 | $13,000 | – | 912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |